Literature DB >> 7120008

Course and prognosis after colectomy and ileostomy for inflammatory bowel disease in childhood and adolescence.

J S Hyams, R J Grand, A H Colodny, S R Schuster, A Eraklis.   

Abstract

The clinical course of 32 pediatric patients with inflammatory bowel disease (ulcerative colitis--18, Crohn's disease--14) after colectomy and ileostomy was investigated. Specific indications for surgery were: ulcerative colitis (severe colitis--50%, chronic disease--50%); Crohn's disease (fistulae--28%, severe colitis--28%, chronic disease--21%, hemorrhage--14%, growth failure--7%). Proctectomy was performed at the time of colectomy in 72% of patients with ulcerative colitis and in 64% of those with Crohn's disease. Major post-operative complications (stomal dysfunction without documented recurrent disease, obstruction, abscess, bleeding) were observed in 60% of all patients regardless of diagnosis. Histologically documented recurrent disease developed in 42% of the patients with Crohn's disease (mean follow-up: 5 yr) despite removal of all affected bowel. Ileal disease at the time of surgery appeared to be a poor prognostic factor. Sexual activity was either improved or unchanged in sexually active patients. Impotence was not observed in any of the male patients. Despite complications and recurrent disease, the majority (75%) of patients viewed colectomy and ileostomy as improving the quality of their life.

Entities:  

Mesh:

Year:  1982        PMID: 7120008     DOI: 10.1016/s0022-3468(82)80498-3

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Psychosocial sequelae of stoma surgery for inflammatory bowel disease in childhood.

Authors:  B Lask; J Jenkins; L Nabarro; I Booth
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

2.  Total Abdominal Colectomies With Proctectomy Are Associated With Higher 30-Day Readmission Rates in Children With Ulcerative Colitis.

Authors:  Matthew D Egberg; Michael Phillips; Joseph A Galanko; Michael Kappelman
Journal:  Inflamm Bowel Dis       Date:  2021-03-15       Impact factor: 5.325

Review 3.  Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine.

Authors:  Federica Giachero; Andreas Jenke; Matthias Zilbauer
Journal:  Expert Rev Clin Immunol       Date:  2021-06-28       Impact factor: 4.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.